Johnson Johnson Completes Acquisition of Ci:z Holdings Co., Ltd.

Stocks and Financial Services Press Releases Friday January 18, 2019 08:25
NEW BRUNSWICK, New Jersey--18 Jan--PRNewswire/InfoQuest
Acquisition Expands J&J's Portfolio of Science-based Dermocosmetic Beauty Products

Johnson & Johnson (NYSE:JNJ) today announced the completion of the acquisition of Ci:z Holdings Co., Ltd. (TYO: 4924) (the "Company") for a total purchase price of approximately JPY / CNY230 billion. The acquisition was completed through a series of transactions that included an all-cash tender offer to acquire publicly held shares of the Company for JPY / CNY5,900 per share. Johnson & Johnson plans to acquire the remaining shares of the Company that were not tendered in the tender offer through a share consolidation under Japanese law during the first half of 2019 and take appropriate actions to delist the Company from the Tokyo Stock Exchange.

The Company, which markets the DR. CI:LABO, LABO LABO and GENOMER line of skincare products, will now become part of the Johnson & Johnson Family of Consumer Companies.

"The addition of DR. CI:LABO, LABO LABO and GENOMER to our franchise strengthens our growing beauty portfolio with unique dermocosmetic innovation," said Jorge Mesquita, Worldwide Chairman, Johnson & Johnson Consumer. "We are very pleased to complete this important transaction and look forward to bringing efficacious, science-backed skincare products to our health and beauty consumers around the world."

Any EPS impact of the transaction will be included in the 2019 guidance provided on Johnson & Johnson's Q4 2018 earnings call.
About Johnson & Johnson

At Johnson & Johnson, we believe good health is the foundation of vibrant lives, thriving communities and forward progress. That's why for more than 130 years, we have aimed to keep people well at every age and every stage of life. Today, as the world's largest and most broadly-based health care company, we are committed to using our reach and size for good. We strive to improve access and affordability, create healthier communities, and put a healthy mind, body and environment within reach of everyone, everywhere. We are blending our heart, science and ingenuity to profoundly change the trajectory of health for humanity.

NOTE CONCERNING FORWARD-LOOKING STATEMENTS

This press release contains "forward-looking statements" as defined in the Private Securities Litigation Reform Act of 1995 regarding the potential transaction between Johnson & Johnson and the Company. The reader is cautioned not to rely on these forward-looking statements. These statements are based on current expectations of future events. If underlying assumptions prove inaccurate or known or unknown risks or uncertainties materialize, actual results could vary materially from the expectations and projections of Johnson & Johnson and the Company. Risks and uncertainties include, but are not limited to: the satisfaction of closing conditions for the transaction, including the receipt of regulatory approvals for the transaction; the tender of the requisite amount of the outstanding shares of the Company; the possibility that the transaction will not be completed in the expected timeframe or at all; the potential that the expected benefits and opportunities of the transaction, if completed, may not be realized or may take longer to realize than expected; uncertainty of commercial success for new and existing products; manufacturing difficulties and delays; economic conditions, including currency exchange and interest rate fluctuations; competition, including technological advances, new products and patents attained by competitors; changes to applicable laws and regulations, including tax laws and domestic and foreign health care reforms; adverse litigation or government action; changes in behavior and spending patterns or financial distress of purchasers of health care products and services; and trends toward health care cost containment. In addition, if and when the transaction is consummated, there will be risks and uncertainties related to the ability of the Johnson & Johnson Family of Companies to successfully integrate the products, employees and operations of the Company, as well as the ability to ensure continued performance or market growth of the Company's products. A further list and description of these risks, uncertainties and other factors can be found in Johnson & Johnson's publicly available filings with the U.S. Securities and Exchange Commission. Copies of these filings, as well as subsequent filings, are available online at www.sec.gov, www.jnj.com or on request from Johnson & Johnson. Johnson & Johnson does not undertake to update any forward-looking statement as a result of new information or future events or developments.

Logo - https://mma.prnewswire.com/media/403394/Johnson_and_Johnson_Logo.jpg

Latest Press Release

Fitch Rates EASY BUY#s THB Senior Unsecured Bonds at #AA+(tha)#

Fitch Ratings (Thailand) has assigned a National Long-Term Rating of 'AA+(tha)' to EASY BUY Public Company Limited's (EB; AA+(tha)/Stable) upcoming issue of senior unsecured bonds. The bonds will have a tenor of up to three years. KEY RATING DRIVERS The...

5m USD Ampleforth Sale on Tokinex Completed in 11 Seconds

Tokinex, the Bitfinex and Ethfinex Initial Exchange Offering platform, today announces the successful completion of its first sale in just 11 seconds. The Ampleforth sale of 5 million USD reflected ten percent of AMPL's token supply. Successful...

Photo Release: KBank wins three big awards at The Asian Banker Thailand Country Awards 2019

Mr. Suwat Techawatanawana (center), Executive Vice President, Ms. Suporn Sunthornrohit (right), First Senior Vice President, and Ms. Arporn Sirisrisakunchai, Head of Marketing Campaign Intelligence Department of KBank, represented KBank to receive three...

Photo Release: KTC offers cardmembers up to Bt. 2,000 cash backs at Caltex gas stations.

Ms. Pittaya Vorapanyasakul, Executive Vice President - Credit Card, "KTC" or Krungthai Card Public Company Limited, jointly with Mr. Salman Saadat, Country Chairman and General Manager - Products, Chevron (Thailand) Limited, a world standard gas station...

Fitch Ratings: Large Thai Food Retailers Face Challenges to Maintain Margins

Fitch Ratings-Bangkok-13 June 2019: The margins of Thailand's leading food retailers will come under pressure over the medium term due to fiercer competition, higher fixed costs per unit of sales from smaller store sizes and increasing proportion of...

Related Topics